Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917. - Wikidata - awgldk - TriplyDB

Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917.

Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917.

http://www.wikidata.org/entity/Q35528860

about

Selenium for preventing cancer Dietary antioxidants and prostate cancer: a review Chemoprevention of cancer: current evidence and future prospects Friend or foe? The current epidemiologic evidence on selenium and human cancer risk Lifestyle and dietary factors in the prevention of lethal prostate cancer Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Dietary supplements and disease prevention - a global overview.Ongoing Use of Data and Specimens From National Cancer Institute-Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology Program.Selenium and Prostate Cancer: Analysis of Individual Participant Data From Fifteen Prospective Studies.Health risk assessment of environmental selenium: Emerging evidence and challenges (Review)Selenomethionine and methyl selenocysteine: multiple-dose pharmacokinetics in selenium-replete men.Prostate cancer and the influence of dietary factors and supplements: a systematic review.Chemoprevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia (HGPIN): a systematic review and adjusted indirect treatment comparison L-selenomethionine does not protect against testosterone plus 17β-estradiol-induced oxidative stress and preneoplastic lesions in the prostate of NBL rats Dietary patterns and prostate cancer risk: report from the population based ULSAM cohort study of Swedish men.Selenium and Human Health: Witnessing a Copernican Revolution?Diet and prostate cancer prevention.Dietary supplements and cancer prevention: balancing potential benefits against proven harms.A Perspective on Prostate Carcinogenesis and Chemoprevention Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck Methylseleninic Acid Superactivates p53-Senescence Cancer Progression Barrier in Prostate Lesions of Pten-Knockout Mouse.Cancer chemoprevention research with selenium in the post-SELECT era: Promises and challenges.Toward understanding success and failures in the use of selenium for cancer prevention.Future directions in the prevention of prostate cancer.TMPRSS2:ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia.Chemoprevention of prostate cancer: an updated view.Bioavailability of phytochemicals and its enhancement by drug delivery systems.Oxidative stress in prostate cancer: changing research concepts towards a novel paradigm for prevention and therapeutics.Advances in prostate cancer chemoprevention: a translational perspective.Effects of deranged metabolism on epigenetic changes in cancer.Ornithine Decarboxylase Is Sufficient for Prostate Tumorigenesis via Androgen Receptor Signaling.Selenium status and cardiovascular diseases: meta-analysis of prospective observational studies and randomized controlled trials.Methylseleninic acid suppresses pancreatic cancer growth involving multiple pathways.A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?Prostate disease risk factors among a New Zealand cohort.Overcoming obstacles in the design of cancer anorexia/weight loss trials.Methylseleninic acid induces NAD(P)H:quinone oxidoreductase-1 expression through activation of NF-E2-related factor 2 in Chang liver cells.Nutraceuticals in prostate cancer therapeutic strategies and their neo-adjuvant use in diverse populations The association between Selenium and Prostate Cancer: a Systematic Review and Meta-Analysis Prostate cancer chemoprevention by natural agents: Clinical evidence and potential implications

P2860

Q24197798-229812BD-79EA-4754-8753-58E9B24AF18D Q26996474-8A5A116E-8A92-4FBD-99DC-27C5AB685052 Q27000363-2DE786D0-48C8-4D16-A3A9-4533ADA08600 Q27015669-3A20A6D3-BB30-4807-BE11-AA6D7AF54CA3 Q27025735-ACE90E01-D281-481F-847F-1FE05FFF72E9 Q29620308-ACE48E9E-B5B0-4F4D-8024-EA64C56E4944 Q30251418-8177421E-13D8-46FB-8BD2-591202D28E2E Q31001228-49B8AC48-86F0-499A-BC99-F60754B41B72 Q31112967-F31DAB9C-0ADD-4672-83BA-5C7D85675D56 Q33671643-DDB68ED0-85EA-4C4E-ABB1-4502BCD0E0F7 Q33688644-40868F3F-BA00-45AC-AA0F-06845FB31E6A Q33813910-1A46E6BD-C22D-4A6E-836C-3B251F6CDC63 Q33829606-870395EC-FF56-4AE2-B9F7-0C549A9AA8F4 Q34025688-6C4760EE-BD8F-4543-A2C0-B4B1FCFA52DA Q34039257-C4825C2C-7E0D-49AA-8468-2AF376D16952 Q34480665-EA650A6B-EC18-4D25-8B28-E0D4A35599B3 Q35002417-14413343-3D6C-4371-8665-3EBB03B604BC Q35962084-1496F014-FF6E-4928-8F70-AFB415B38A8E Q36116269-A1506D5C-A4F1-48F5-9CA0-9D0E83894476 Q36143844-F2104F4F-32D0-40B9-A727-29B8100AA071 Q36446645-BD64C6C6-4FDC-42B8-8714-533DEAFF4431 Q36769227-30FD22CC-3BF0-47BA-ADCD-65F88F3F5F29 Q36945715-5FFE351B-A83B-409E-92F3-229193241255 Q37279094-5318E779-68F5-4A0B-96CD-A8CC7FDCE8EC Q37460447-8F63941D-E99A-404D-B6EF-E88D2150E05D Q37975188-0D879A78-A49B-4279-A4D3-16856F2AA07D Q38084084-13B0E57D-5BB9-4679-B640-9B2EBCFE6EEB Q38106640-C82A2FC9-8EED-4FBB-9D3E-3451E89C3252 Q38107513-5039B26A-678E-4C18-916F-4CAD6C3DA1DA Q38335029-797858EA-39A8-4314-BCAF-D7D5E76A5489 Q38738879-1F7A34DA-FFC5-4C84-AE70-E494BD12401C Q39004826-38308CB4-A45E-476E-9445-81C1632CA490 Q39032407-5F2E8656-F985-40F1-A807-CC59709FF302 Q41039911-D265C873-576A-4D15-A542-5F5F62C48C31 Q45330916-75843E37-9891-4E0F-A54C-2D014B8476E2 Q47194265-31B89441-7625-428B-B811-35F8A5C0E4A0 Q49172799-18A6A8BD-077C-4F0C-B367-181C459DC5AF Q57109257-669B8C2A-2583-4473-A7DF-C71B0DD03754 Q57111011-78EEAFE8-8E5B-4239-BA44-4E70CAC1FB2E Q57112620-6A57F4C6-D6F7-41D5-A29D-F774BE03C5FA

P2860

Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917.

http://www.wikidata.org/entity/Q35528860

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Phase III trial of selenium to ...... thelial neoplasia: SWOG S9917.

@ast

Phase III trial of selenium to ...... thelial neoplasia: SWOG S9917.

@en

type

label

Phase III trial of selenium to ...... thelial neoplasia: SWOG S9917.

@ast

Phase III trial of selenium to ...... thelial neoplasia: SWOG S9917.

@en

prefLabel

Phase III trial of selenium to ...... thelial neoplasia: SWOG S9917.

@ast

Phase III trial of selenium to ...... thelial neoplasia: SWOG S9917.

@en

P1433

Q35528860-BC8C8267-F51F-402D-9595-000BE765AB44

P1476

Q35528860-A104FB3B-43D6-45EC-B47E-614A209E3529

P2093

Q35528860-052C5EBD-C6D6-4CD5-9633-B7F53789A36E

Q35528860-09A8AE23-5469-4ACA-B842-3F657EA8B7B1

Q35528860-09F17945-8B80-44B1-9EBE-4110F772BAB2

Q35528860-0AFB6287-3E9D-4A76-9E68-6E5A43D85E91

Q35528860-346004D9-903E-4752-99E9-4C8DB1251887

Q35528860-538E213F-9B46-4D43-A0A1-5271D5FB8A11

Q35528860-5F8023C0-C6FB-420B-B793-795D1D9E6ACF

Q35528860-61D61AEA-2347-483E-B5D5-18B27502CBF6

Q35528860-63E28E71-3AC0-4A53-890E-8780E0660936

Q35528860-6F0B78FD-166F-4FAE-9C4A-5662A9B1D806

P2860

Q35528860-017129B8-2AD0-4CB7-BAFB-89C667656E5A

Q35528860-06CE6362-8646-451A-B9D5-51EA46E05531

Q35528860-0B6F05DA-8897-471C-81A5-4C8D5D84ED0A

Q35528860-16E9A251-ADD4-4E9F-BB37-7921749333FF

Q35528860-26F40861-CFF6-4FA2-9F2A-83160181B5C4

Q35528860-28BC59BA-793B-4605-892B-7AF4E872A0C3

Q35528860-2EFBDE0F-DE11-46E9-993B-8D6E7DF59146

Q35528860-35A2F58B-D345-4E4A-A657-693BAE9C0F14

Q35528860-488F5ED1-A644-4634-9B2F-97200155FC3A

Q35528860-493DC7D0-C921-49A3-B677-DCC1A023CCFC

P304

Q35528860-45718900-681B-49D0-88A4-4C1D4E385A55

P31

Q35528860-C24D202F-B922-44C6-A05D-15B2CC4F8B75

P356

Q35528860-AC5413FC-705A-4499-9EFA-1316CE0B7894

P433

Q35528860-C317FFC3-7EED-4CC3-827C-B8EB5018E408

P478

Q35528860-1979F144-F0EC-47CC-A523-D06F78F199DE

P577

Q35528860-F0638089-BD15-4C7C-8023-140972DBD98E

P698

Q35528860-AA4FF9BA-5D0D-414A-8A6E-C89D1D10FB5A

P921

Q35528860-3B21B424-849C-4172-A360-3017A178BBA9

Q35528860-C2C07636-C0B0-4E0B-BA2B-3BFFFD67DB76

P932

Q35528860-8A8F6490-D6B5-45ED-858C-80E707C70B47

P356

1940-6207.CAPR-10-0343

P1433

Cancer Prevention Research

P1476

Phase III trial of selenium to ...... thelial neoplasia: SWOG S9917.

@en

P2093

Benjamin Ely

http://www.w3.org/2001/XMLSchema#string

Catherine M Tangen

http://www.w3.org/2001/XMLSchema#string

David F Jarrard

http://www.w3.org/2001/XMLSchema#string

David P Wood

http://www.w3.org/2001/XMLSchema#string

David S Alberts

http://www.w3.org/2001/XMLSchema#string

Donna L Berry

http://www.w3.org/2001/XMLSchema#string

E David Crawford

http://www.w3.org/2001/XMLSchema#string

Eric A Klein

http://www.w3.org/2001/XMLSchema#string

Howard L Parnes

http://www.w3.org/2001/XMLSchema#string

Ian M Thompson

http://www.w3.org/2001/XMLSchema#string

P2860

Rethinking screening for breast cancer and prostate cancer

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Effect of dutasteride on the risk of prostate cancer.

Regulatory approval of cancer risk-reducing (chemopreventive) drugs: moving what we have learned into the clinic

Progression from high-grade prostatic intraepithelial neoplasia to cancer: a randomized trial of combination vitamin-E, soy, and selenium.

A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival.

Prostatic intraepithelial neoplasia is a risk factor for cancer.

The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association.

Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer.

P304

1761-1769

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1940-6207.CAPR-10-0343

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21896650

http://www.w3.org/2001/XMLSchema#string

P921

High-grade prostatic intraepithelial neoplasia

phase III clinical trial

P932

3208719

http://www.w3.org/2001/XMLSchema#string